Alzheimer’s research is latest casualty in Trump administration war against ‘DEI’
Summary
The Trump administration has canceled several National Institutes of Health (NIH) grants funding Alzheimer’s disease and brain health research at Emory University and the University of Pittsburgh. These cancellations appear to target studies examining the effects of racism on brain health and continue a pattern of cutting federal funding related to diversity, equity, and inclusion (DEI).Key Facts
- At least three NIH grants totaling $15 million were canceled, affecting research on how discrimination impacts long-term brain health.
- The canceled grants were held by researchers at Emory University and the University of Pittsburgh.
- Many of these studies focused on the higher risk of Alzheimer’s disease and dementia among Black Americans compared to white Americans.
- The Trump administration previously canceled billions of dollars in federal grants linked to DEI, leading to lawsuits by research institutions.
- A federal judge ruled earlier grant cancellations illegal, but the Supreme Court allowed the administration to cancel $783 million in NIH funding in a separate ruling.
- These new cancellations are not part of the earlier court case and may be a legal test by the administration.
- NIH grants are usually awarded for several years and reviewed regularly, but many Alzheimer’s research grants were delayed in 2025 and early 2026.
- Researchers say the cancellations disrupt important Alzheimer’s disease research and reflect political interference in science.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
